References 137 REFERENCES 1. Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008;300:1311-6. 2. Wu JM, Matthews CA, Conover MM, Pate V, Jonsson Funk M. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol 2014;123:1201-6. 3. DeLancey JO, Low LK, Miller JM, Patel DA, Tumbarello JA. Graphic integration of causal factors of pelvic floor disorders: an integrated life span model. Am J Obstet Gynecol 2008;199:610. e1-. e5. 4. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010;21:5-26. 5. Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:10-7. 6. Pham T, Burgart A, Kenton K, Mueller ER, Brubaker L. Current use of pelvic organ prolapse quantification by AUGS and ICS members. Urogynecology 2011;17:67-9. 7. Boyd SS, O’Sullivan D, Tulikangas P. Use of the Pelvic Organ Quantification System (POP-Q) in published articles of peer-reviewed journals. International Urogynecology Journal 2017;28:171923. 8. Bradley CS, Nygaard IE. Vaginal wall descensus and pelvic floor symptoms in older women. Obstet Gynecol 2005;106:759-66. 9. Barber MD. Symptoms and outcome measures of pelvic organ prolapse. Clin Obstet Gynecol 2005;48:648-61. 10. De Boer T, Salvatore S, Cardozo L, et al. Pelvic organ prolapse and overactive bladder. Neurourology and Urodynamics: Official Journal of the International Continence Society 2010;29:309. 11. Lo T-S, Uy-Patrimonio MC, Kao CC, Chua S, Huang T-X, Wu M-P. Urodynamics mixed type urinary incontinence with advanced pelvic organ prolapse, management and outcomes. Sci Rep 2020;10:1944. 12. Liedl B, Goeschen K, Durner L. Current treatment of pelvic organ prolapse correlated with chronic pelvic pain, bladder and bowel dysfunction. Current Opinion in Urology 2017;27:274-81. 13. DeLancey JO. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol 1994;170:1713-23. 14. Bø K, Anglès-Acedo S, Batra A, et al. International urogynecology consultation chapter 3 committee 2; conservative treatment of patient with pelvic organ prolapse: Pelvic floor muscle training. Int Urogynecol J 2022;33:2633-67. 15. Dumoulin C, Hunter KF, Moore K, et al. Conservative management for female urinary incontinence and pelvic organ prolapse review 2013: Summary of the 5th International Consultation on Incontinence. Neurourol Urodyn 2016;35:15-20. 16. Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2011:Cd003882. 17. Thakar R. Pessaries for treatment of pelvic organ prolapse and incontinence. Female Pelvic Medicine and Reconstructive Surgery: Clinical Practice and Surgical Atlas: McGraw-Hill Education Ltd Columbus; 2013:339-52. 18. Mao M, Ai F, Zhang Y, et al. Predictors for unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: a prospective study. BJOG 2018;125:1434-40. 19. Sarma S, Ying T, Moore KH. Long-term vaginal ring pessary use: discontinuation rates and adverse events. BJOG 2009;116:1715-21. 20. Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJ. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev 2012;1:Cd005429. 21. Kelleher C, Hakimi Z, Zur R, et al. Efficacy and tolerability of mirabegron compared with antimuscarinic monotherapy or combination therapies for overactive bladder: a systematic review and network meta-analysis. Eur Urol 2018;74:324-33. 22. Phillips C, Hillard T, Salvatore S, Toozs-Hobson P, Cardozo L. Lasers in gynaecology. Eur J Obstet Gynecol Reprod Biol 2020;251:146-55.
RkJQdWJsaXNoZXIy MTk4NDMw